Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jieyu Decoction
- Development stage
- Preclinical
- Lead developer
- Shanghai Hospital of Integrated Traditional Chinese and Western Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Jieyu Decoction is a traditional Chinese medicine (TCM) herbal formula developed for the treatment of migraine and comorbid depression [chictr]. Formulated as an oral decoction, it is designed to harmonize Qi dynamics and alleviate symptoms of both headache and emotional distress. Jieyu Decoction is being evaluated in clinical trials to assess its efficacy in reducing headache severity, improving migraine-specific quality of life, and alleviating depressive symptoms compared to standard pharmacological treatments such as venlafaxine [chictr].
- Other names
- Jieyu Decotion
Beyond the preview
Go deeper on Jieyu Decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jieyu Decoction.